Xtant Medical Holdings, Inc.XTNTNYSE
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank64
3Y CAGR+94.8%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
+94.8%/yr
Annual compound
Percentile
P64
Within normal range
vs 3Y Ago
7.4x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202421.18%
202369.28%
20227.06%
20212.86%
2020-21.23%
2019-2.84%
2018-19.31%
2017-7.06%
201643.16%
201561.83%